Mirae Asset Global Investments Co., Ltd. Innoviva, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,088 shares of INVA stock, worth $38,377. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,088
Previous 2,086
0.1%
Holding current value
$38,377
Previous $36,000
2.78%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding INVA
# of Institutions
241Shares Held
77.7MCall Options Held
52.8KPut Options Held
800-
Black Rock Inc. New York, NY9.63MShares$177 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$134 Million39.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.31MShares$116 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$115 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.92MShares$90.4 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.28B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...